News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CytRx Corporation (CYTR) to Present at the Rodman & Renshaw14th Annual Global Investment Conference


9/4/2012 10:15:31 AM

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical company specializing in oncology, today announced that President and Chief Executive Officer Steven A. Kriegsman and Vice President of Business Development David J. Haen will present a business update at the Rodman & Renshaw 14th Annual Global Investment Conference on Tuesday, September 11 at 11:15 a.m. Eastern time (8:15 a.m. Pacific time) in the Starlight Center of the Waldorf=Astoria in New York City.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES